Bone Biologics Corp Quarterly Operating Income (Loss) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bone Biologics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q2 2024.
  • Bone Biologics Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$810K, a 73.4% increase year-over-year.
  • Bone Biologics Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.95M, a 43% increase year-over-year.
  • Bone Biologics Corp annual Operating Income (Loss) for 2023 was -$9.43M, a 157% decline from 2022.
  • Bone Biologics Corp annual Operating Income (Loss) for 2022 was -$3.67M, a 232% decline from 2021.
  • Bone Biologics Corp annual Operating Income (Loss) for 2021 was -$1.1M, a 33.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.95M -$810K +$2.23M +73.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$7.18M -$904K +$2.24M +71.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$9.43M -$1.16M +$127K +9.87% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$9.56M -$2.08M -$862K -70.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$8.69M -$3.04M -$2.57M -548% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$6.12M -$3.15M -$2.46M -356% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$3.67M -$1.29M -$827K -180% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$2.84M -$1.22M -$989K -431% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.85M -$469K -$237K -102% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.61M -$689K -$509K -281% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.1M -$460K -$254K -123% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$849K -$230K -$84K -57.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$765K -$232K -$99.2K -74.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$666K -$181K +$159K +46.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$825K -$206K +$71.2K +25.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$896K -$146K +$155K +51.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.05M -$133K +$547K +80.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.6M -$340K +$849K +71.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q4 2019 -$2.45M -$278K +$961K +77.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$3.41M -$301K -$706K -174% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-15
Q2 2019 -$2.7M -$679K +$181K +21% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-15
Q1 2019 -$2.88M -$1.19M -$92.5K -8.44% Jan 1, 2019 Mar 31, 2019 10-Q 2021-04-15
Q4 2018 -$2.79M -$1.24M +$71.8K +5.48% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.86M $405K +$1.54M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.4M -$860K -$2.84M -144% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.56M -$1.1M +$1.06M +49.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$2.63M -$1.31M +$1.8M +57.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$4.43M -$1.13M +$2.73M +70.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$7.16M $1.97M +$6.31M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$13.5M -$2.16M +$6.94M +76.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$20.4M -$3.11M +$4.48M +59% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$24.9M -$3.86M -$889K -29.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 -$24M -$4.34M -$3.83M -749% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$20.2M -$9.1M -$8.18M -886% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$12M -$7.59M -$6.81M -866% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$5.19M -$2.97M -$1.23M -71.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$3.95M -$511K -$194K -61.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$3.76M -$923K -$750K -431% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$3.01M -$786K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$1.73M -$1.62M -1355% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$316K -$105K -49.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$174K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 -$119K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$211K Apr 1, 2013 Jun 30, 2013 8-K 2014-09-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.